Nasus Pharma prices $15M private placement

* Clinical-stage biopharma company Nasus Pharma (NSRX [https://seekingalpha.com/symbol/NSRX]) priced [https://seekingalpha.com/pr/20395149-nasus-pharma-announces-pricing-of-15_0-million-private-placement] $15M private placement that involves selling 2,695,425 ordinary shares and matching warrants at $5.565 per share-and-warrant unit, a premium to the prior NYSE American close.
* Warrants carry a $6.53 exercise price, become immediately exercisable, and expire after two years or 30 trading days post-NS002 pivotal study results.
* New and existing investors, including board members, participated.
* Net proceeds will fund NS002's pivotal trial advancement, first-in-human studies for other intranasal products, and general corporate needs, alongside existing cash.
* The private placement is expected to close on or about February 12, 2026.

MORE ON NASUS PHARMA LTD.

* Seeking Alpha’s Quant Rating on Nasus Pharma Ltd. [https://seekingalpha.com/symbol/NSRX/ratings/quant-ratings]
* Historical earnings data for Nasus Pharma Ltd. [https://seekingalpha.com/symbol/NSRX/earnings]
* Financial information for Nasus Pharma Ltd. [https://seekingalpha.com/symbol/NSRX/income-statement]